textochbilcontainer
A BUSINESS MODEL WITH FASTER TIME TO MARKET AND LOWER DEVELOPMENT RISK COMPARED WITH CONVENTIONAL DRUG DEVELOPMENT
textochbilcontainer
RESULTS FROM THE TWO PHASE 3 STUDIES SHOW THAT MOB-015 HAS UNIQUE ANTIFUNGAL EFFECT
textochbilcontainer
Our goal is to get the first market approval for MOB ‐ 015 in 2023 in Europe.
Moberg Pharma is a rapidly growing Swedish pharmaceutical company commercializing proprietary, acquired and licensed products in the global market. Initially, the company specialized in the treatment of skin diseases, with a focus on treatments for nail fungus.
Stockvalue
- All pressreleases
- Regulatory
2023-03-09 | Press release
2023-02-07 | Press release
2022-11-08 | Press release
2023-03-09 | Press release
2023-02-07 | Press release
2022-11-08 | Press release
